{"DataElement":{"publicId":"2763213","version":"1","preferredName":"Therapeutic Procedure Administered Indicator","preferredDefinition":"The indicator that describes whether or not therapy was administered.","longName":"2763211v1.0:2784450v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"2763211","version":"1","preferredName":"Therapeutic Procedure Administered","preferredDefinition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process._The act of having given something (e.g., a medication or test).","longName":"THERAP_PRO_ADMST","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2512834","version":"1","preferredName":"Therapeutic Procedure","preferredDefinition":"An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","longName":"C49236","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B89860A-B9D6-3798-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-08-21","endDate":null,"createdBy":"UMLLOADER_AGNIS","dateCreated":"2006-08-21","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2233610","version":"1","preferredName":"Administered","preferredDefinition":"Given.","longName":"C25382","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Administered","conceptCode":"C25382","definition":"The act of having given something (e.g., a medication or test).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F95D94B9-D864-2792-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-13","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-06-13","modifiedBy":"ONEDATA","dateModified":"2005-06-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"51828FAE-F5A7-38E9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-07-08","endDate":null,"createdBy":"STURGILLJ","dateCreated":"2008-07-08","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2784450","version":"1","preferredName":"Yes No Unk ND NA Indicator","preferredDefinition":"The preferred Value Domain to indicate a question with permissible values of yes, no, unknown, not done or not applicable.","longName":"Y_N_U_ND_NA_IND","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"25","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Yes","valueDescription":"Yes","ValueMeaning":{"publicId":"2567168","version":"1","preferredName":"Yes","longName":"2567168","preferredDefinition":"The affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes","conceptCode":"C49488","definition":"The affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D36D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-13","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-13","modifiedBy":"GDEEN","dateModified":"2024-01-02","changeDescription":"12/29/2006 - Updated with NCI Thesaurus definition.","administrativeNotes":"2022.12.29 Alt VM added per ticket request CADSR0001837. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"56A428C5-E072-6CDD-E044-0003BA3F9857","beginDate":"2008-09-11","endDate":null,"createdBy":"ALEYR","dateCreated":"2008-09-11","modifiedBy":"ALEYR","dateModified":"2008-09-11","deletedIndicator":"No"},{"value":"No","valueDescription":"No ","ValueMeaning":{"publicId":"2567170","version":"1","preferredName":"No","longName":"2567170","preferredDefinition":"The non-affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D36F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-13","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-13","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":"Updated to add NCIt concept relationship. Updated VM Short Name to be the Public ID to be consistent with current convention for VM Short Name - DW 10-03-2022","administrativeNotes":"2022.12.29 Alt VM added per ticket request CADSR0001837. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"56A428C5-E07E-6CDD-E044-0003BA3F9857","beginDate":"2008-09-11","endDate":null,"createdBy":"ALEYR","dateCreated":"2008-09-11","modifiedBy":"ALEYR","dateModified":"2008-09-11","deletedIndicator":"No"},{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"2565695","version":"1","preferredName":"Unknown","longName":"2565695","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CDAC-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-02-26","endDate":null,"createdBy":"MEDVEDOH","dateCreated":"2003-02-26","modifiedBy":"MMADDINENI","dateModified":"2024-02-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"56A428C5-E08A-6CDD-E044-0003BA3F9857","beginDate":"2008-09-11","endDate":null,"createdBy":"ALEYR","dateCreated":"2008-09-11","modifiedBy":"ALEYR","dateModified":"2008-09-11","deletedIndicator":"No"},{"value":"Not Applicable","valueDescription":"Not applicable","ValueMeaning":{"publicId":"2581003","version":"1","preferredName":"Not applicable","longName":"2581003v1.00","preferredDefinition":"Determination of a value is not relevant in the current context.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Applicable","conceptCode":"C48660","definition":"Determination of a value is not relevant in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0978-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-12-31","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-12-31","modifiedBy":"CLOHNES","dateModified":"2023-11-09","changeDescription":null,"administrativeNotes":"2023.3.6 Added Alt VM-COG. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"56A428C5-E0A2-6CDD-E044-0003BA3F9857","beginDate":"2008-09-11","endDate":null,"createdBy":"ALEYR","dateCreated":"2008-09-11","modifiedBy":"ALEYR","dateModified":"2008-09-11","deletedIndicator":"No"},{"value":"Not Done","valueDescription":"Not Done: C49484","ValueMeaning":{"publicId":"2579172","version":"1","preferredName":"Not Done: C49484","longName":"2579172","preferredDefinition":"Indicates a task, process or examination that has either not been initiated or completed.\r\n","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Done","conceptCode":"C49484","definition":"Indicates a task, process or examination that has either not been initiated or not been completed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0251-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-05-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-05-04","modifiedBy":"KUMMEROA","dateModified":"2022-07-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"59223A59-341F-0A9E-E044-0003BA3F9857","beginDate":"2008-09-11","endDate":null,"createdBy":"ALEYR","dateCreated":"2008-10-13","modifiedBy":"ALEYR","dateModified":"2008-10-13","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2784449","version":"1","preferredName":"Yes No Unknown Not Done Not Applicable Indicator","preferredDefinition":"The affirmative response to a question or activity.:The non-affirmative response to a question.:Not known, not observed, not recorded, or refused.:Indicates a task, process or examination that has either not been initiated or completed.:Determination that a value is not relevant in the current context.:An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.","longName":"C49488:C49487:C17998:C49484:C4","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes","conceptCode":"C49488","definition":"The affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"5"},{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Not Done","conceptCode":"C49484","definition":"Indicates a task, process or examination that has either not been initiated or not been completed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Not Applicable","conceptCode":"C48660","definition":"Determination of a value is not relevant in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Indicator","conceptCode":"C25180","definition":"An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"56A428C5-E04C-6CDD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-09-11","endDate":null,"createdBy":"ALEYR","dateCreated":"2008-09-11","modifiedBy":"ONEDATA","dateModified":"2008-09-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"56A428C5-E05D-6CDD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-09-11","endDate":null,"createdBy":"ALEYR","dateCreated":"2008-09-11","modifiedBy":"GDEEN","dateModified":"2023-05-12","changeDescription":". Modified def to preferred def per caDSR meeting. No versioning needed. AK 2/8/16","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"10115208","version":"1","longName":"QA Test CS","context":"TEST","ClassificationSchemeItems":[{"publicId":"10115209","version":"1","longName":"QA Test CSI","context":"TEST"}]},{"publicId":"2695319","version":"1","longName":"NMDP: CDEs to review","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"3234637","version":"1","longName":"2131r2: Immune Deficiencies Post-HSCT Data","context":"NHLBI"},{"publicId":"2964928","version":"1","longName":"2011r1: ALL Pre-HSCT Data","context":"NHLBI"},{"publicId":"2964931","version":"1","longName":"2014r1: MDS Pre-HSCT Data","context":"NHLBI"},{"publicId":"2964890","version":"1","longName":"2018r1: Lymphoma Pre-HSCT Data","context":"NHLBI"},{"publicId":"2964929","version":"1","longName":"2012r1: CML Pre-HSCT Data","context":"NHLBI"},{"publicId":"2964893","version":"1","longName":"2025r1: Central Nervous System Tumor Pre-HSCT Data","context":"NHLBI"},{"publicId":"2964930","version":"1","longName":"2013r1: CLL Pre-HSCT Data","context":"NHLBI"},{"publicId":"2964919","version":"1","longName":"2138r1: Mucopolysaccharidosis and Other Storage Diseases Post-HSCT Data","context":"NHLBI"},{"publicId":"2964927","version":"1","longName":"2010r1: Acute Myelogenous Leukemia Pre-HSCT Data","context":"NHLBI"},{"publicId":"2964898","version":"1","longName":"2038r1: Mucopolysaccharidosis and Other Storage Diseases Pre-HSCT Data","context":"NHLBI"},{"publicId":"2964899","version":"1","longName":"2022r1: Testicular / Germ Cell Cancer Pre-HSCT Data","context":"NHLBI"},{"publicId":"2964905","version":"1","longName":"2112r1: CML Post-HSCT Data","context":"NHLBI"},{"publicId":"2964904","version":"1","longName":"2111r1: All Post-HSCT Data","context":"NHLBI"},{"publicId":"2964903","version":"1","longName":"2110r1: Acute Myelogenous Leukemia Post-HSCT Data","context":"NHLBI"},{"publicId":"2964915","version":"1","longName":"2125r1: Central Nervous System Tumor Post-HSCT Data","context":"NHLBI"},{"publicId":"2964916","version":"1","longName":"2126r1: Neuroblastoma Post-HSCT Data","context":"NHLBI"},{"publicId":"2964906","version":"1","longName":"2113r1: CLL Post-HSCT Data","context":"NHLBI"},{"publicId":"3638517","version":"1","longName":"2031r2: Immune Deficiencies Pre-HSCT Data","context":"NHLBI"},{"publicId":"3279244","version":"1","longName":"2039r1: Hemophagocytic Lymphohistiocytosis Pre-HSCT Data","context":"NHLBI"},{"publicId":"2964888","version":"1","longName":"2016r1: Myeloma Pre-HSCT Data","context":"NHLBI"},{"publicId":"2964908","version":"1","longName":"2116r1: Myeloma Post-HSCT Data","context":"NHLBI"}]},{"publicId":"6685474","version":"1","longName":"Artificial Neural Network Algorithm for BRIDG Mapping","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6685478","version":"1","longName":"Testing Set – Moderately Different","context":"NCIP"}]}],"AlternateNames":[{"name":"CLLP_PHPI_therapy_ynu","type":"NMDP_FN","context":"NHLBI"},{"name":"all_base_tx_prior_prep_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"cml_base_tx_prior_prep_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"VOD_CS_therapy_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"VOD_THPY_defibrotide_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"mds_base_tx_prior_prep_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"HPST_AGHD_p_in_vivo_immntox_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"HPST_AGHD_pentostatin_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"HPST_AGHD_alemtuzumab_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"HPST_AGHD_alg_als_atg_ats_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"HPST_AGHD_blind_trial_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"HPST_AGHD_bortezomib_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"HPST_AGHD_cortico_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"HPST_AGHD_cyclophosphamide_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"HPST_AGHD_cyclosporin_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"HPST_AGHD_daclizumab_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"HPST_AGHD_etanercept_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"HPST_AGHD_extra_cp_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"HPST_AGHD_fk_506_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"HPST_AGHD_in_vivo_immunotox_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"HPST_AGHD_in_vivo_mono_anti_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"HPST_AGHD_infliximab_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"HPST_AGHD_jak2_inhib_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"HPST_AGHD_methotrexate_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"HPST_AGHD_mycophenolate_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"HPST_AGHD_oth_agent_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"lym_base_tx_prior_prep_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"cns_base_tx_prior_prep_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"cll_base_tx_prior_prep_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"bc_post_tx_given_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"muc_base_pt_treated_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"bc_base_tx_prior_prep_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"HPST_AGHD_p_alg_als_atg_ats_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"HPST_AGHD_pr_blind_trial_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"bc_base_tx_prior_surg_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"bc_post_tx_prior_surg_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"tc_base_tx_prior_prep_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"tc_base_tx_prior_surg_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"muc_post_pt_treated_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"tc_post_plnd_trt_given_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"aml_base_tx_prior_prep_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"muc_base_trt_enzy_rplc_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"muc_base_trt_gene_tx_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"muc_base_trt_oth_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"muc_base_trt_subst_dep_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"muc_post_trt_enzy_rplc_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"muc_post_trt_gene_tx_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"muc_post_trt_oth_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"muc_post_trt_subst_dep_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"id_post_alemtuz_given_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"id_post_daclizum_given_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"id_post_etanerce_given_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"id_post_inflixim_given_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"id_post_muromon_given_yn ","type":"NMDP_FN","context":"NHLBI"},{"name":"id_post_othr_mab_given_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"id_post_rituxima_given_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"id_prep_trtment_given_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"felh_base_cyclosporin_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"felh_base_inmtx_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"felh_base_ivig_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"felh_base_othr_drug_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"felh_base_rad_thrpy_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"felh_base_steroids_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"felh_base_vp16_vm27_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"amy_post_tx_last_rpt_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"all_post_plan_tx_prtcl_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"aml_post_plan_tx_prtcl_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"cll_post_plan_tx_prtcl_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"cml_post_planned_trt_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"cns_post_pln_trt_given_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"neu_post_plan_tx_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"felh_base_trt_prep_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"id_post_atg_given_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"id_post_csa_given_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"id_post_cytoxan_given_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"id_post_ecp_given_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"id_post_lenalid_given_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"id_post_mmf_given_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"id_post_monoclab_given_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"id_post_oth_drug_given_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"id_post_sirolim_given_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"id_post_systemic_given_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"id_post_tacrolim_given_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"id_post_thalido_given_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"id_post_topical_given_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"id_prep_alemtuz_given_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"id_prep_atg_given_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"id_prep_cort_sys_given_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"id_prep_cort_top_given_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"id_prep_csa_given_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"id_prep_cytoxan_given_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"id_prep_daclizum_given_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"id_prep_etanerce_given_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"id_prep_monoclab_given_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"id_prep_inflixim_given_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"id_prep_mmf_given_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"id_prep_othr_drug_give_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"id_prep_othr_mab_given_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"id_prep_rituxima_given_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"id_prep_tacrolim_given_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"PreTed_prime_dis_hct_cml_therapy_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"LYMpost_therapy_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"LYMpre_therapy_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"AMLpre_therapy_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"AMLpost_therapy_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"ALLpre_therapy_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"ALLpost_therapy_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"mye_base_tx_prior_prep_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"PCDpost_therapy_ynu","type":"NMDP_FN","context":"NHLBI"},{"name":"PCDpre_therapy_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"MDSpre_therapy_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"mye_post_tx_planned_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"JMMLpre_therapy_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"MACpost_therapy_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"MACpre_therapy_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"HLHpre_therapy_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"XLPpost_assess_cns_vasc_therapy_ynu","type":"NMDP_FN","context":"NHLBI"},{"name":"XLPpost_assess_colitis_therapy_ynu","type":"NMDP_FN","context":"NHLBI"},{"name":"XLPpost_assess_oth_vasc_therapy_ynu","type":"NINDS Alt Name","context":"NHLBI"},{"name":"XLPpost_assess_pulm_vasc_therapy_ynu","type":"NMDP_FN","context":"NHLBI"},{"name":"HPST_AGHD_pr_cortico_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"HPST_AGHD_pr_cyclosporin_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"HPST_AGHD_pr_extra_cp_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"HPST_AGHD_pr_fk_506_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"HPST_AGHD_pr_mycophenolate_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"HPST_AGHD_pr_oth_agent_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"HPST_AGHD_pr_sirolimus_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"HPST_AGHD_puva_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"HPST_AGHD_sirolimus_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"HPST_AGHD_tocilizumab_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"HPST_CGHD_aldesleukin_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"HPST_CGHD_alemtuzumab_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"HPST_CGHD_alg_als_atg_ats_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"HPST_CGHD_azathioprine_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"HPST_CGHD_blind_trial_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"HPST_CGHD_bortezomib_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"HPST_CGHD_cortico_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"HPST_CGHD_cyclosporin_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"HPST_CGHD_daclizumab_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"HPST_CGHD_etanercept_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"HPST_CGHD_extra_cp_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"HPST_CGHD_fk_506_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"HPST_CGHD_hydroxychloroq_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"HPST_CGHD_infliximab_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"HPST_CGHD_methotrexate_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"HPST_CGHD_interleuk_inhib_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"HPST_CGHD_jak2_inhib_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"HPST_CGHD_mycophenolate_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"HPST_CGHD_oth_agent_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"HPST_CGHD_pentostatin_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"HPST_CGHD_photothrpy_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"HPST_CGHD_rituximab_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"HPST_CGHD_sirolimus_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"HPST_CGHD_tyrosine_kin_inhb_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"HPST_ES_therapy_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"HPST_OF_therapy_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"HPST_OF_tm_therapy_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"XLPpre_dis_stat_prep_cns_vasc_therapy_ynu","type":"NMDP_FN","context":"NHLBI"},{"name":"XLPpre_dis_stat_prep_colitis_therapy_ynu","type":"NMDP_FN","context":"NHLBI"},{"name":"XLPpre_dis_stat_prep_oth_vasc_therapy_ynu","type":"NMDP_FN","context":"NHLBI"},{"name":"XLPpre_dis_stat_prep_pulm_vasc_therapy_ynu","type":"NMDP_FN","context":"NHLBI"},{"name":"TPST_PHCT_therapy_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"XLPpre_assess_diag_prep_therapy_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"PDDpost_therapy_ynu","type":"NMDP_FN","context":"NHLBI"},{"name":"PDDpre_therapy_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"VOD_THPY_therapy_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"RITNbase_therapy_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"RITNfup_therapy_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"CPST_CRS_therapy_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"CMLP_PHPI_therapy_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"TDIS_CML_therapy_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"CMLF_PHPI_therapy_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"CMLF_PLTH_therapy_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"CLLF_DRPI_therapy_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"CLLF_PHPI_therapy_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"ALLP_PT_therapy_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"ALLF_PT_therapy_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"CPRE_STPC_alemtuzumab_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"CPRE_STPC_alg_als_atg_ats_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"CPRE_STPC_anthracycline_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"CPRE_STPC_bleomycin_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"CPRE_STPC_busulfan_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"CPRE_STPC_carboplatin_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"CPRE_STPC_carmustine_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"CPRE_STPC_ccnu_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"CPRE_STPC_cisplatin_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"CPRE_STPC_cladribine_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"CPRE_STPC_cortico_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"CPRE_STPC_cyclophosphamide_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"CPRE_STPC_cytarabine_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"CPRE_STPC_dasatinib_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"CPRE_STPC_daunorubicin_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"CPRE_STPC_dexamethasone_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"CPRE_STPC_doxorubicin_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"CPRE_STPC_etoposide_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"CPRE_STPC_fludarabine_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"CPRE_STPC_gemtuzumab_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"CPRE_STPC_idarubicin_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"CPRE_STPC_ifosfamide_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"CPRE_STPC_imatinib_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"CPRE_STPC_it_cytarabine_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"CPRE_STPC_it_therapy_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"CPRE_STPC_it_thiotepa_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"CPRE_STPC_mAb_ind","type":"NMDP_FN","context":"NHLBI"},{"name":"CPRE_STPC_mab_othr_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"CPRE_STPC_melphalan_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"CPRE_STPC_methylprednisolon_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"CPRE_STPC_mitoxantrone_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"CPRE_STPC_mtx_it_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"CPRE_STPC_nilotinib_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"CPRE_STPC_nitrosourea_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"CPRE_STPC_oth_anthracy_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"CPRE_STPC_oth_cortico_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"CPRE_STPC_oth_drug_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"CPRE_STPC_oth_it_drug_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"CPRE_STPC_oth_nitrosourea_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"CPRE_STPC_oth_tki_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"CPRE_STPC_paclitaxel_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"CPRE_STPC_prednisone_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"CPRE_STPC_rituximab_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"CPRE_STPC_rubidazone_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"CPRE_STPC_teniposide_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"CPRE_STPC_thiotepa_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"CPRE_STPC_treosulfan_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"CPRE_STPC_tyros_kin_inhibit_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"CPST_TOX_therapy_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"AMLP_PHTH_therapy_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"AMLF_PT_therapy_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"LYMpost_THRPY_therapy_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"LYMpre_thrpy_therapy_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"PerformedProcedure:tbd","type":"HCT_BRIDG_5","context":"NHLBI"},{"name":"CPST_TOX_neurotox_thrpy_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"COG","type":"USED_BY","context":"COG"},{"name":"DLIN_DLI_dis_trtmnt_adm_yn","type":"NMDP_FN","context":"NHLBI"},{"name":"CA_TX_RCV_IND","type":"COG Form Element","context":"COG"}],"ReferenceDocuments":[{"name":"Was a therapeutic procedure a","type":"Preferred Question Text","description":"Was a therapeutic procedure administered?","url":null,"context":"NHLBI"},{"name":"Was therapy given?","type":"Alternate Question Text","description":"Was therapy given?","url":null,"context":"NHLBI"},{"name":"Was treatment given for the disease?","type":"Alternate Question Text","description":"Was treatment given for the disease?","url":null,"context":"NHLBI"},{"name":"Specify therapy:","type":"Alternate Question Text","description":"Specify therapy:","url":null,"context":"NHLBI"},{"name":"Was treatment given?","type":"Alternate Question Text","description":"Was treatment given?","url":null,"context":"NHLBI"},{"name":"ALG, ALS, ATG, ATS","type":"Alternate Question Text","description":"ALG, ALS, ATG, ATS","url":null,"context":"NHLBI"},{"name":"Anthracycline","type":"Alternate Question Text","description":"Anthracycline","url":null,"context":"NHLBI"},{"name":"Daunorubicin","type":"Alternate Question Text","description":"Daunorubicin","url":null,"context":"NHLBI"},{"name":"Doxorubicin (adriamycin)","type":"Alternate Question Text","description":"Doxorubicin (adriamycin)","url":null,"context":"NHLBI"},{"name":"Idarubicin","type":"Alternate Question Text","description":"Idarubicin","url":null,"context":"NHLBI"},{"name":"Rubidazone","type":"Alternate Question Text","description":"Rubidazone","url":null,"context":"NHLBI"},{"name":"Other anthracycline","type":"Alternate Question Text","description":"Other anthracycline","url":null,"context":"NHLBI"},{"name":"Bleomycin (BLM, Blenoxane)","type":"Alternate Question Text","description":"Bleomycin (BLM, Blenoxane)","url":null,"context":"NHLBI"},{"name":"Busulfan (Myleran)","type":"Alternate Question Text","description":"Busulfan (Myleran)","url":null,"context":"NHLBI"},{"name":"Carboplatin","type":"Alternate Question Text","description":"Carboplatin","url":null,"context":"NHLBI"},{"name":"Cisplatin (Platinol, CDDP)","type":"Alternate Question Text","description":"Cisplatin (Platinol, CDDP)","url":null,"context":"NHLBI"},{"name":"Cladribine (2-CdA, Leustatin)","type":"Alternate Question Text","description":"Cladribine (2-CdA, Leustatin)","url":null,"context":"NHLBI"},{"name":"Corticosteroids","type":"Alternate Question Text","description":"Corticosteroids","url":null,"context":"NHLBI"},{"name":"Methylprednisolone (Solu-Medrol)","type":"Alternate Question Text","description":"Methylprednisolone (Solu-Medrol)","url":null,"context":"NHLBI"},{"name":"Prednisone","type":"Alternate Question Text","description":"Prednisone","url":null,"context":"NHLBI"},{"name":"Dexamethasone","type":"Alternate Question Text","description":"Dexamethasone","url":null,"context":"NHLBI"},{"name":"Other corticosteroid","type":"Alternate Question Text","description":"Other corticosteroid","url":null,"context":"NHLBI"},{"name":"Cyclophosphamide (Cytoxan)","type":"Alternate Question Text","description":"Cyclophosphamide (Cytoxan)","url":null,"context":"NHLBI"},{"name":"Cytarabine (Ara-C)","type":"Alternate Question Text","description":"Cytarabine (Ara-C)","url":null,"context":"NHLBI"},{"name":"Etoposide (VP-16, VePesid)","type":"Alternate Question Text","description":"Etoposide (VP-16, VePesid)","url":null,"context":"NHLBI"},{"name":"Fludarabine","type":"Alternate Question Text","description":"Fludarabine","url":null,"context":"NHLBI"},{"name":"Ifosfamide","type":"Alternate Question Text","description":"Ifosfamide","url":null,"context":"NHLBI"},{"name":"Imatinib mesylate (STI571, Gleevec)","type":"Alternate Question Text","description":"Imatinib mesylate (STI571, Gleevec)","url":null,"context":"NHLBI"},{"name":"Intrathecal chemotherapy","type":"Alternate Question Text","description":"Intrathecal chemotherapy","url":null,"context":"NHLBI"},{"name":"Intrathecal cytarabine (IT Ara-C)","type":"Alternate Question Text","description":"Intrathecal cytarabine (IT Ara-C)","url":null,"context":"NHLBI"},{"name":"Intrathecal methotrexate (IT MTX)","type":"Alternate Question Text","description":"Intrathecal methotrexate (IT MTX)","url":null,"context":"NHLBI"},{"name":"Intrathecal thiotepa","type":"Alternate Question Text","description":"Intrathecal thiotepa","url":null,"context":"NHLBI"},{"name":"Other intrathecal drug","type":"Alternate Question Text","description":"Other intrathecal drug","url":null,"context":"NHLBI"},{"name":"Melphalan (L-Pam)","type":"Alternate Question Text","description":"Melphalan (L-Pam)","url":null,"context":"NHLBI"},{"name":"Mitoxantrone","type":"Alternate Question Text","description":"Mitoxantrone","url":null,"context":"NHLBI"},{"name":"Monoclonal antibody","type":"Alternate Question Text","description":"Monoclonal antibody","url":null,"context":"NHLBI"},{"name":"Alemtuzumab (Campath)","type":"Alternate Question Text","description":"Alemtuzumab (Campath)","url":null,"context":"NHLBI"},{"name":"Rituximab (Rituxan, anti CD20)","type":"Alternate Question Text","description":"Rituximab (Rituxan, anti CD20)","url":null,"context":"NHLBI"},{"name":"Gemtuzumab (Mylotarg, anti CD33)","type":"Alternate Question Text","description":"Gemtuzumab (Mylotarg, anti CD33)","url":null,"context":"NHLBI"},{"name":"Other mAb","type":"Alternate Question Text","description":"Other mAb","url":null,"context":"NHLBI"},{"name":"Nitrosourea","type":"Alternate Question Text","description":"Nitrosourea","url":null,"context":"NHLBI"},{"name":"Carmustine (BCNU)","type":"Alternate Question Text","description":"Carmustine (BCNU)","url":null,"context":"NHLBI"},{"name":"CCNU (Lomustine)","type":"Alternate Question Text","description":"CCNU (Lomustine)","url":null,"context":"NHLBI"},{"name":"Other nitrosourea","type":"Alternate Question Text","description":"Other nitrosourea","url":null,"context":"NHLBI"},{"name":"Paclitaxel (Taxol, Xyotax)","type":"Alternate Question Text","description":"Paclitaxel (Taxol, Xyotax)","url":null,"context":"NHLBI"},{"name":"Teniposide (VM26)","type":"Alternate Question Text","description":"Teniposide (VM26)","url":null,"context":"NHLBI"},{"name":"Thiotepa","type":"Alternate Question Text","description":"Thiotepa","url":null,"context":"NHLBI"},{"name":"Other drug","type":"Alternate Question Text","description":"Other drug","url":null,"context":"NHLBI"},{"name":"Was therapy given?","type":"Application Standard Question Text","description":"Was therapy given?","url":null,"context":"NHLBI"},{"name":"Was the recipient receiving therapy?","type":"Alternate Question Text","description":"Was the recipient receiving therapy?","url":null,"context":"NHLBI"},{"name":"Was any treatment given?","type":"Alternate Question Text","description":"Was any treatment given?","url":null,"context":"NHLBI"},{"name":"Was the recipient treated?","type":"Alternate Question Text","description":"Was the recipient treated?","url":null,"context":"NHLBI"},{"name":"Was any therapy given?","type":"Alternate Question Text","description":"Was any therapy given?","url":null,"context":"NHLBI"},{"name":"Was therapy given since the date of last report?","type":"Alternate Question Text","description":"Was therapy given since the date of last report?","url":null,"context":"NHLBI"},{"name":"Corticosteroids (systemic)","type":"Alternate Question Text","description":"Corticosteroids (systemic)","url":null,"context":"NHLBI"},{"name":"Alemtuzumab","type":"Alternate Question Text","description":"Alemtuzumab","url":null,"context":"NHLBI"},{"name":"Anti CD25","type":"Alternate Question Text","description":"Anti CD25","url":null,"context":"NHLBI"},{"name":"Cyclosporine","type":"Alternate Question Text","description":"Cyclosporine","url":null,"context":"NHLBI"},{"name":"Extra-corporeal photopheresis (ECP)","type":"Alternate Question Text","description":"Extra-corporeal photopheresis (ECP)","url":null,"context":"NHLBI"},{"name":"Etanercept","type":"Alternate Question Text","description":"Etanercept","url":null,"context":"NHLBI"},{"name":"FK 506","type":"Alternate Question Text","description":"FK 506","url":null,"context":"NHLBI"},{"name":"Infliximab","type":"Alternate Question Text","description":"Infliximab","url":null,"context":"NHLBI"},{"name":"In vivo immunotoxin","type":"Alternate Question Text","description":"In vivo immunotoxin","url":null,"context":"NHLBI"},{"name":"Mycophenolate mofetil (MMF)","type":"Alternate Question Text","description":"Mycophenolate mofetil (MMF)","url":null,"context":"NHLBI"},{"name":"Pentostatin","type":"Alternate Question Text","description":"Pentostatin","url":null,"context":"NHLBI"},{"name":"PUVA","type":"Alternate Question Text","description":"PUVA","url":null,"context":"NHLBI"},{"name":"Sirolimus","type":"Alternate Question Text","description":"Sirolimus","url":null,"context":"NHLBI"},{"name":"Tocilizumab","type":"Alternate Question Text","description":"Tocilizumab","url":null,"context":"NHLBI"},{"name":"JAK 2 inhibitors","type":"Alternate Question Text","description":"JAK 2 inhibitors","url":null,"context":"NHLBI"},{"name":"Blinded randomized trial","type":"Alternate Question Text","description":"Blinded randomized trial","url":null,"context":"NHLBI"},{"name":"Other agent","type":"Alternate Question Text","description":"Other agent","url":null,"context":"NHLBI"},{"name":"Aldesleukin","type":"Alternate Question Text","description":"Aldesleukin","url":null,"context":"NHLBI"},{"name":"Azathioprine","type":"Alternate Question Text","description":"Azathioprine","url":null,"context":"NHLBI"},{"name":"Bortezomib","type":"Alternate Question Text","description":"Bortezomib","url":null,"context":"NHLBI"},{"name":"Interleukin inhibitors","type":"Alternate Question Text","description":"Interleukin inhibitors","url":null,"context":"NHLBI"},{"name":"Hydroxychloroquine","type":"Alternate Question Text","description":"Hydroxychloroquine","url":null,"context":"NHLBI"},{"name":"Methotrexate (MTX)","type":"Alternate Question Text","description":"Methotrexate (MTX)","url":null,"context":"NHLBI"},{"name":"UV therapy","type":"Alternate Question Text","description":"UV therapy","url":null,"context":"NHLBI"},{"name":"Rituximab","type":"Alternate Question Text","description":"Rituximab","url":null,"context":"NHLBI"},{"name":"Tyrosine kinase inhibitors (TKI)","type":"Alternate Question Text","description":"Tyrosine kinase inhibitors (TKI)","url":null,"context":"NHLBI"},{"name":"Was therapy given since the date of the last report for reasons other than relapse, persistent, or progressive disease?","type":"Alternate Question Text","description":"Was therapy given since the date of the last report for reasons other than relapse, persistent, or progressive disease?","url":null,"context":"NHLBI"},{"name":"Defibrotide","type":"Alternate Question Text","description":"Defibrotide","url":null,"context":"NHLBI"},{"name":"N-acetylcysteine","type":"Alternate Question Text","description":"N-acetylcysteine","url":null,"context":"NHLBI"},{"name":"Tissue plasminogen activator (TPA)","type":"Alternate Question Text","description":"Tissue plasminogen activator (TPA)","url":null,"context":"NHLBI"},{"name":"Ursodiol","type":"Alternate Question Text","description":"Ursodiol","url":null,"context":"NHLBI"},{"name":"Other therapy","type":"Alternate Question Text","description":"Other therapy","url":null,"context":"NHLBI"},{"name":"Was therapy given for TMA?","type":"Alternate Question Text","description":"Was therapy given for TMA?","url":null,"context":"NHLBI"},{"name":"Ibrutinib","type":"Alternate Question Text","description":"Ibrutinib","url":null,"context":"NHLBI"},{"name":"Macrolide antibiotic","type":"Alternate Question Text","description":"Macrolide antibiotic","url":null,"context":"NHLBI"},{"name":"Montelukast","type":"Alternate Question Text","description":"Montelukast","url":null,"context":"NHLBI"},{"name":"Was a particular therapy administered?","type":"Alternate Question Text","description":"Was a particular therapy administered?","url":null,"context":"NHLBI"},{"name":"Treosulfan","type":"Alternate Question Text","description":"Treosulfan","url":null,"context":"NHLBI"},{"name":"Dasatinib","type":"Alternate Question Text","description":"Dasatinib","url":null,"context":"NHLBI"},{"name":"Nilotinib","type":"Alternate Question Text","description":"Nilotinib","url":null,"context":"NHLBI"},{"name":"Other tyrosine kinase inhibitor","type":"Alternate Question Text","description":"Other tyrosine kinase inhibitor","url":null,"context":"NHLBI"},{"name":"Was therapy given since the date of the last report for reasons other than relapse or persistent disease?","type":"Alternate Question Text","description":"Was therapy given since the date of the last report for reasons other than relapse or persistent disease?","url":null,"context":"NHLBI"},{"name":"Was therapy given since the date of the last report for reasons other than relapse or progressive disease?","type":"Alternate Question Text","description":"Was therapy given since the date of the last report for reasons other than relapse or progressive disease?","url":null,"context":"NHLBI"},{"name":"Did the recipient receive any therapy between 7 days prior to the date of infection diagnosis and the date of infusion?","type":"Alternate Question Text","description":"Did the recipient receive any therapy between 7 days prior to the date of infection diagnosis and the date of infusion?","url":null,"context":"NHLBI"},{"name":"Was maintenance therapy given after treatment of relapse / progression since the date of last report?","type":"Alternate Question Text","description":"Was maintenance therapy given after treatment of relapse / progression since the date of last report?","url":null,"context":"NHLBI"},{"name":"Was treatment given for maintenance after treatment of relapse / progression?","type":"Alternate Question Text","description":"Was treatment given for maintenance after treatment of relapse / progression?","url":null,"context":"NHLBI"},{"name":"Was treatment given for maintenance after treatment of relapse/progression?","type":"Alternate Question Text","description":"Was treatment given for maintenance after treatment of relapse/progression?","url":null,"context":"NHLBI"},{"name":"Was treatment given for relapse or progression?","type":"Alternate Question Text","description":"Was treatment given for relapse or progression?","url":null,"context":"NHLBI"},{"name":"Was therapy given since the date of last report for reasons other than relapsed, persistent, or progressive disease including detection of minimal residual disease or decreases / loss of donor chimerism?","type":"Alternate Question Text","description":"Was therapy given since the date of last report for reasons other than relapsed, persistent, or progressive disease including detection of minimal residual disease or decreases / loss of donor chimerism?","url":null,"context":"NHLBI"},{"name":"Was therapy given since the date of last report for reasons other than relapsed, persistent, or progressive disease including detection of minimal residual disease or decreased/ loss of donor chimerism?","type":"Alternate Question Text","description":"Was therapy given since the date of last report for reasons other than relapsed, persistent, or progressive disease including detection of minimal residual disease or decreased/ loss of donor chimerism?","url":null,"context":"NHLBI"},{"name":"Was therapy received to treat hyperlipidemia?","type":"Alternate Question Text","description":"Was therapy received to treat hyperlipidemia?","url":null,"context":"NHLBI"},{"name":"Was therapy given for hormone deficiency / short stature?","type":"Alternate Question Text","description":"Was therapy given for hormone deficiency / short stature?","url":null,"context":"NHLBI"},{"name":"Was an agent/s administered to treat the infection?","type":"Alternate Question Text","description":"Was an agent/s administered to treat the infection?","url":null,"context":"COG"},{"name":"NMDP Text 1","type":"Alternate Question Text","description":"Was therapy to treat disease given prior to the DLI?","url":null,"context":"NHLBI"},{"name":"NMDP Text 2","type":"Alternate Question Text","description":"Was therapy given for reasons other than relapsed, persistent, or progressive disease?","url":null,"context":"NHLBI"},{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"Did the patient receive cancer therapy for disease progression or recurrence, or subsequent malignant neoplasm, in addition to that of AHOD1331?","url":null,"context":"COG"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"51828FAE-F5C3-38E9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-07-08","endDate":null,"createdBy":"STURGILLJ","dateCreated":"2008-07-08","modifiedBy":"KUMMEROA","dateModified":"2023-01-31","changeDescription":".11/16/12mn-added cs & alt names for 2110,2111,2112,2113,2125,2126 - using this CDE in place of CDE 2934712 (plan maintenance) per review. Added CSI for 2031/2131r2. AK 12/7/12 Added alt names/CSIs for 2031/2131r2. AK 12/7/12 Added alt name/ASQT for 2400. AK 10/10/13 Modified AQT to removed timepoint. AK 2/24/14. 4/8/14mn-added alt name for 2118.. 4/24/14mn-added alt name for 2018r3. Added AQT for 2034. AK 5/5/14 System generated def displayed as alt def. AK 10/13/14 . 11/19/14mn-added alt name for 2010r3. .11/26/14mn-added alt name for 2110r3.. 12/19/14mn-added alt name for 2011r4. 8/27/15mn-added alt name for 2116r1. AQT added for 2450r4 review. AK 2/17/16 Added AQTs for 2100r4. AK 2/22/16. 2/26/16mn-add aqt. Added alt name for 2015r3. AK 4/8/16 Added alt names for 2x19r3. AK 4/11/16 Added alt name for 2034r3/2039r3. AK 4/20/16 Added alt names for 2x56r3. AK 4/25/16 Alt names added for 2553. AK 7/21/16 Field names added for 5000/5100. AK 9/14/16 Added AQTs per RR. AK 12/2/16Added AQTS for 4000. AK 5/7/17 Aded AQT for 2110r4. AK 6/21/17; Added HCT_BRIDG5 alternate name - RR 2018-12-23. Added AQT. 08/13/2019 KMM. AQT added for 2114r4. 02/27/2020 KMM. AQT added for 2100r7. 03/29/2021 KMM","administrativeNotes":"2023.1.31 AQT and Alt SN added per ticket request CADSR0001985. ak 2022.8.25 Added alt name for ticket request CADSR0001454. ak","unresolvedIssues":null,"deletedIndicator":"No"}}